SEC Stock Data Quick Answer Longevity Health Holdings, Inc. reported Total Revenue of $1.91 million for fiscal year 2025. Longevity Health Holdings, Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $1.91M +3701.4% 2024 $50.3K — 2023 $0.00 — Quarterly Total Revenue Quarter Ending Total Revenue YoY QoQ September 30, 2025 $425.9K +1975.5% -15.4% … Read more
Quick Answer Longevity Health Holdings, Inc. reported Total Revenue of $1.91 million for fiscal year 2025. Longevity Health Holdings, Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 Total Revenue $1.91M+3701.4% $50.3K $0.00 — — Revenue (ASC 606) $1.91M+3701.4% $50.3K $0.00 — — Net Income -$6.91M+33.4% -$10.37M+32.9% -$15.45M-70.6% -$9.05M-2648.0% -$329.4K Diluted EPS … Read more
Quick Answer AEI INCOME & GROWTH FUND XXII LTD PARTNERSHIP reported Operating Income of $22.4 thousand for fiscal year 2025. AEI INCOME & GROWTH FUND XXII LTD PARTNERSHIP Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $22.4K +200.8% 2024 -$22.2K -148.2% 2023 $46.2K -30.2% 2022 $66.1K +0.6% 2021 $65.7K -49.0% 2020 … Read more
Quick Answer AEI INCOME & GROWTH FUND XXII LTD PARTNERSHIP reported Cash and Equivalents of $472.9 thousand for fiscal year 2025. AEI INCOME & GROWTH FUND XXII LTD PARTNERSHIP Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $472.9K -48.3% 2024 $914.8K +234.4% 2023 $273.6K +6.8% 2022 $256.2K -80.2% 2021 … Read more
Quick Answer AEI INCOME & GROWTH FUND XXII LTD PARTNERSHIP reported Total Assets of $5.18 million for fiscal year 2025. AEI INCOME & GROWTH FUND XXII LTD PARTNERSHIP Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $5.18M -21.6% 2024 $6.61M -4.3% 2023 $6.90M -5.3% 2022 $7.29M +0.4% 2021 $7.26M -10.2% 2020 … Read more
Quick Answer AEI INCOME & GROWTH FUND XXII LTD PARTNERSHIP reported Total Assets of $5.18 million for fiscal year 2025. AEI INCOME & GROWTH FUND XXII LTD PARTNERSHIP — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Assets $5.18M-21.6% $6.61M-4.3% $6.90M-5.3% $7.29M+0.4% $7.26M-10.2% $8.09M-0.3% Cash and Equivalents $472.9K-48.3% $914.8K+234.4% $273.6K+6.8% $256.2K-80.2% … Read more
Quick Answer WIDEPOINT CORP reported Shares Outstanding of 9.89 million shares for fiscal year 2025. WIDEPOINT CORP Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 9.89M +4.3% 2024 9.49M +6.7% 2023 8.89M +1.9% 2022 8.73M -1.3% 2021 8.84M -0.4% 2020 8.88M +5.8% 2019 8.39M -90.0% 2018 84.11M +1.3% 2017 83.03M +0.4% … Read more
Quick Answer WIDEPOINT CORP reported Gross Profit of $21.01 million for fiscal year 2025. WIDEPOINT CORP Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $21.01M +10.5% 2024 $19.00M +21.5% 2023 $15.65M +7.3% 2022 $14.58M -10.9% 2021 $16.37M -20.0% 2020 $20.46M +17.7% 2019 $17.38M +13.8% 2018 $15.27M +11.5% 2017 $13.69M -2.3% 2016 … Read more
Quick Answer WIDEPOINT CORP reported Operating Income of -$2.78 million for fiscal year 2025. WIDEPOINT CORP Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$2.78M -48.1% 2024 -$1.88M +49.2% 2023 -$3.70M +81.1% 2022 -$19.63M -3331.3% 2021 $607.6K -81.1% 2020 $3.22M +264.0% 2019 $885.3K +564.9% 2018 -$190.4K +94.5% 2017 -$3.46M +16.8% 2016 … Read more
Quick Answer WIDEPOINT CORP reported R&D Expense of $0.00 for fiscal year 2018. WIDEPOINT CORP R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2018 $0.00 -100.0% 2017 $219.1K -68.6% 2016 $699.0K +3.9% 2015 $673.1K +40.2% 2014 $480.1K +552.7% 2013 $73.6K — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ September 30, … Read more